SEARCH RESULTS FOR: "Tag: EDIT"
REFINE YOUR SEARCH:
RECENT
Last Week(1)
Last Month(2)
ARTICLES/BLOGS
2019(2)
2018(4)
2017(2)
CATEGORIES
Analyst Update(2)
Buzz Stocks(1)
Midday Market Check(1)
Opening View(1)
Stocks On the Move(3)
Unusual Trading Activity(1)

2/8/2019 11:27 AM
BTIG is chiming in on healthcare names today, and for gene editing stocks Editas Medicine Inc (NASDAQ:EDIT) and Intellia Therapeutics Inc (NASDAQ:NTLA), this resulted in fresh "buy" ratings and impr...
1/22/2019 2:33 PM
Stocks are sinking to start off the holiday-abbreviated week. Among the names struggling are metals specialist Arconic Inc (NYSE:ARNC), gene editing stock Editas Medicine Inc (NASDAQ:EDIT), and weed ...
9/21/2018 9:24 AM
Gene editing stocks have cooled in recent months after a big start to 2018. However, CRISPR Therapeutics AG (NASDAQ:CRSP) and Editas Medicine Inc (NASDAQ:EDIT) are back in focus today following anal...
7/16/2018 2:28 PM
U.S. stocks are sluggish today, as lower oil prices weigh on the major indexes. One group in particular that's under pressure is gene editing stocks, following another concerning study on CRISP/Ca...
1/29/2018 12:05 PM
Stocks are pulling back, with the Dow Jones Industrial Average (DJI) dropping more than 160 points at its intraday low -- pressured by Apple's (AAPL) iPhone X production concerns ahead of Thursday...

Welcome to Schaeffer's Investment Research! We are a privately held provider of stock and options trading recommendations, options education, and market commentary, headquartered in Cincinnati, Ohio. Founded in 1981 by industry pioneer Bernie Schaeffer, we've since become a trusted source of research and analysis for individual investors and major financial media outlets alike.







Partner Center